Rozanne C de Veer

5PUBLICATIONS
16CO-AUTHORS
PharmacogenomicsPacific Peoples biomedical and clinical scienceCell physiologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 14, 2026
A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for Optimisation.

Ellen Werner, Maria C B van Hooff, Gemma H X Weijsters

|Sep 23, 2022
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.

Rozanne C de Veer, Maren H Harms, Christophe Corpechot

|Dec 17, 2021
Measurement properties of the PBC-40 and PBC-27: a Dutch validation study.

Rozanne C de Veer, Geraldine da Silva, Maria C van Hooff

|Dec 18, 2019
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis.

Maren H Harms, Rozanne C de Veer, Willem J Lammers

|Jul 31, 2019
Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment.

Joany E Kreijne, Rozanne C de Veer, Nanne K de Boer

Pageof 1

Frequent Collaborators

1 joint publications

Joany E Kreijne

1 joint publications

Sofia A W Moorsel

1 joint publications

Maren H Harms

1 joint publications

Pietro Invernizzi